Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study
Author:
Affiliation:
1. UCB Pharma; 208 Bath Road Slough SL1 3WE UK
2. Eli Lilly and Company Limited; Erl Wood Manor, Windlesham GU20 6PH UK
3. Pfizer; 610 Main Street Cambridge 02139 MA USA
4. Pfizer; Neusentis, The Portway Building, Granta Park Cambridge CB21 6GS UK
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pst.1675/fullpdf
Reference29 articles.
1. Getting pharmaceutical R&D back on target;Bunnage;Nature Chemical Biology,2011
2. How to improve R&D productivity: the pharmaceutical industry's grand challenge;Paul;Nature Reviews,2010
3. Phase II failures: 2008-2010;Arrowsmith;Nature Reviews Drug Discovery,2011
4. Bayesian clinical trials;Berry;Nature Reviews,2006
5. Recent developments in improving signal detection and reducing placebo response psychiatric clinical trials;Mallinckrodt;Journal of Psychiatric Research,2011
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Delta Inflation, Optimism Bias, and Uncertainty in Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-09-06
2. Beyond the Classical Type I Error: Bayesian Metrics for Bayesian Designs Using Informative Priors;Statistics in Biopharmaceutical Research;2024-05-31
3. Comparison of Quality of Recovery between Modified Thoracoabdominal Nerves Block through Perichondrial Approach versus Oblique Subcostal Transversus Abdominis Plane Block in Patients Undergoing Total Laparoscopic Hysterectomy: A Pilot Randomized Controlled Trial;Journal of Clinical Medicine;2024-01-25
4. ベイズ流臨床試験における標本サイズ設定：2つの事前分布を用いた推論上の性能に基づく接近法;Japanese Journal of Biometrics;2023-10-31
5. Concept and application of the probability of pharmacological success (PoPS) as a decision tool in drug development: a position paper;Journal of Translational Medicine;2023-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3